Hospitalization as an opportunity to improve lung cancer screening in high-risk patients.

Lung cancer Lung cancer screening Tobacco use disorder

Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
07 Mar 2024
Historique:
received: 28 09 2023
revised: 15 02 2024
accepted: 03 03 2024
medline: 10 3 2024
pubmed: 10 3 2024
entrez: 9 3 2024
Statut: aheadofprint

Résumé

Lung cancer screening with annual low-dose computed tomography (LDCT) in high-risk patients with exposure to smoking reduces lung cancer-related mortality, yet the screening rate of eligible adults is low. As hospitalization is an opportune moment to engage patients in their overall health, it may be an opportunity to improve rates of lung cancer screening. Prior to implementing a hospital-based lung cancer screening referral program, this study assesses the association between hospitalization and completion of lung cancer screening. A retrospective cohort study of evaluated completion of at least one LDCT from 2014 to 2021 using electronic health record data using hospitalization as the primary exposure. Patients aged 55-80 who received care from a university-based internal medicine clinic and reported cigarette use were included. Univariate analysis and logistic regression evaluated the association of hospitalization and completion of LDCT. Cox proportional hazard model examined the time relationship between hospitalization and LDCT. Of the 1935 current smokers identified, 47% had at least one hospitalization, and 21% completed a LDCT during the study period. While a higher proportion of patients with a hospitalization had a LDCT (24%) compared to patients without a hospitalization (18%, p<0.001), there was no association between hospitalization and completion of a LDCT after adjusting for potentially confounding covariates (95%CI 0.680 - 1.149). There was an association between hospitalization time to event and LDCT completion, with hospitalized patients having a lower probability of competing LDCT compared to non-hospitalized patients (HR 0.747; 95% CI 0.611 - 0.914). In a cohort of patients at risk for lung cancer and established within a primary care clinic, only 1 in 4 patients who had been hospitalized completed lung cancer screening with LDCT. Hospitalization events were associated with a lower probability of LDCT completion. Hospitalization is a missed opportunity to refer at-risk patients to lung cancer screening.

Sections du résumé

BACKGROUND BACKGROUND
Lung cancer screening with annual low-dose computed tomography (LDCT) in high-risk patients with exposure to smoking reduces lung cancer-related mortality, yet the screening rate of eligible adults is low. As hospitalization is an opportune moment to engage patients in their overall health, it may be an opportunity to improve rates of lung cancer screening. Prior to implementing a hospital-based lung cancer screening referral program, this study assesses the association between hospitalization and completion of lung cancer screening.
METHODS METHODS
A retrospective cohort study of evaluated completion of at least one LDCT from 2014 to 2021 using electronic health record data using hospitalization as the primary exposure. Patients aged 55-80 who received care from a university-based internal medicine clinic and reported cigarette use were included. Univariate analysis and logistic regression evaluated the association of hospitalization and completion of LDCT. Cox proportional hazard model examined the time relationship between hospitalization and LDCT.
RESULTS RESULTS
Of the 1935 current smokers identified, 47% had at least one hospitalization, and 21% completed a LDCT during the study period. While a higher proportion of patients with a hospitalization had a LDCT (24%) compared to patients without a hospitalization (18%, p<0.001), there was no association between hospitalization and completion of a LDCT after adjusting for potentially confounding covariates (95%CI 0.680 - 1.149). There was an association between hospitalization time to event and LDCT completion, with hospitalized patients having a lower probability of competing LDCT compared to non-hospitalized patients (HR 0.747; 95% CI 0.611 - 0.914).
CONCLUSIONS CONCLUSIONS
In a cohort of patients at risk for lung cancer and established within a primary care clinic, only 1 in 4 patients who had been hospitalized completed lung cancer screening with LDCT. Hospitalization events were associated with a lower probability of LDCT completion. Hospitalization is a missed opportunity to refer at-risk patients to lung cancer screening.

Identifiants

pubmed: 38460398
pii: S1877-7821(24)00032-8
doi: 10.1016/j.canep.2024.102553
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102553

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Benjamin Toll testifies on behalf of plaintiffs who have filed litigation against the tobacco industry.

Auteurs

Ellen M Nielsen (EM)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States. Electronic address: nielsene@musc.edu.

Jingwen Zhang (J)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Justin Marsden (J)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Chloe Bays (C)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

William P Moran (WP)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Patrick D Mauldin (PD)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Leslie A Lenert (LA)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Benjamin A Toll (BA)

Department of Public Health Sciences, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425, United States; MUSC Hollings Cancer Center, 86 Jonathan Lucas Street, Charleston, SC 29425, United States.

Andrew D Schreiner (AD)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Marc Heincelman (M)

Department of Medicine, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, United States.

Classifications MeSH